Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale

Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale

Existing literature highlights the fact that patients with COVID-19 exhibit alterations in the coagulation process and are associated with respiratory and cardiovascular diseases, including acute respiratory distress syndrome and acute cor pulmonale. In this report, we describe the effects of system...

Full description

Bibliographic Details
Main Authors: Djuro Kosanovic, Andrey I. Yaroshetskiy, Natalia A. Tsareva, Zamira M. Merzhoeva, Natalia V. Trushenko, Galina V. Nekludova, Ralph Theo Schermuly, Sergey N. Avdeev
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
SARS-CoV-2
Acute cor pulmonale
ARDS
Recombinant tissue plasminogen activator
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220325686

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220325686

Similar Items